PARACHUTE China Approval Trial

NATerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2017

Conditions
Ischemic Heart Failure
Interventions
DEVICE

Parachute Implant

CardioKinetix's Parachute implant device is suitable for use in isolating the dysfunctional region of the left ventricle in patients with symptoms of heart failure due to ischemic heart disease. Potential benefits of the Parachute implant device are improvement in hemodynamics and the clinical symptoms of heart failure.

Trial Locations (7)

310016

Second Affiliated Hospital of Zhejiang University Medical College, Hangzhou

Unknown

Chinese Academy of Medical Sciences Fu Wai Hospital, Beijing

Peking University First Hospital, Beijing

10th People's Hospital Affiliated to Tongji University, Shanghai

Shanghai Jiaotong University School of Medicine Ruijin Hospital, Shanghai

Zhongshang Hospital of Fudan University, Shanghai

General Hospital of Shenyang Military Region, Shenyang

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Guangzhou Chuangsi Medical Technology Co., Ltd.

UNKNOWN

collaborator

Peking University

OTHER

lead

CardioKinetix, Inc

INDUSTRY